News

Latest news and updates from News.

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
News
June 4, 2026

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection

Lupin Limited (Lupin) and its alliance partner Natco Pharma Limited (Natco) have announced the approval from the United States Food and Drug Administration (U.S. FDA) for Natco’s Abbreviated New Drug Application (ANDA) for Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials. Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is the […]
Article by: IMT News Desk
Maarga Mind Care launches Integrated Maternal Mental Health Program for mothers
News
June 4, 2026

Maarga Mind Care launches Integrated Maternal Mental Health Program for mothers

Maarga Mind Care has introduced its Integrated Maternal Mental Health Program along with the launch of Maarga Divasa – an Integrated Day Care Program. The programs aim at addressing the emotional, psychological, and behavioral aspects of mothers during various stages of motherhood. The launch comes at a time when maternal mental health is increasingly being […]
Article by: IMT News Desk
Goa Among India’s Most Obese States, NFHS-6 Flags Sharp Rise in Lifestyle Diseases
News
June 3, 2026

Goa Among India’s Most Obese States, NFHS-6 Flags Sharp Rise in Lifestyle Diseases

Goa has emerged as one of the most obese states in India, with nearly half of its adult population now overweight or obese, according to the latest National Family Health Survey (NFHS-6) 2023-24 data. The survey, released by the Union Ministry of Health and Family Welfare, reports that 45.1% of women and 43.6% of men […]
Article by: IMT News Desk
Pfizer Launches Bispecific Antibody Elranatamab in India for Advanced Multiple Myeloma
News
June 3, 2026

Pfizer Launches Bispecific Antibody Elranatamab in India for Advanced Multiple Myeloma

Pfizer has announced the commercial launch of its bispecific antibody elranatamab in India for the treatment of adults with relapsed or refractory multiple myeloma, offering a new option for patients who have exhausted multiple prior therapies. The therapy is indicated for patients who have received at least four previous lines of treatment, including a proteasome […]
Article by: IMT News Desk
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes at a price starting INR350
News
June 3, 2026

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes at a price starting INR350

Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM, “Alkem” and its subsidiaries) has launched semaglutide in single-shot pre-filled syringes in multiple dose strengths at a price starting INR350. The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market semaglutide pre-filled syringes for the management of Type 2 diabetes mellitus […]
Article by: IMT News Desk
Oval Fertility Launched in Hyderabad
News
June 2, 2026

Oval Fertility Launched in Hyderabad

 Oval Fertility, a next-gen fertility platform built at the intersection of advanced reproductive science and technology, has announced the launch of its flagship clinic in Hyderabad. Oval Fertility introduces Astec Chrono, Japan’s advanced embryo incubation technology, to India, designed to closely mimic natural developmental conditions while allowing embryologists to monitor embryo development continuously without disturbing […]
Article by: IMT News Desk